CLINICAL_TRIALS
trial_result
· 2019-10-02
Clinical Trial Update: 68Ga-OPS202 Study for Diagnostic Imaging of GEP NET [Phase 1, Phase 2]
Summary
Clinical trial update for 68Ga-OPS202 imaging agent in gastroenteropancreatic neuroendocrine tumors; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Gastroenteropancreatic Neuroendocrine Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-10-02